Developing new contraceptive products for men and women
BIOLOGICAL TESTING FACILITY (BTF) - PRECLINICAL DEVELOPMENT OF CONTRACEPTIVE PRODUCTS
['FUNDING_OTHER'] · SRI INTERNATIONAL · NIH-11193553
This study is exploring new and safe ways to prevent pregnancy by looking at different compounds that can affect ovulation and sperm function, and it's designed for anyone interested in better contraceptive options.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SRI INTERNATIONAL (nih funded) |
| Locations | 1 site (MENLO PARK, UNITED STATES) |
| Trial ID | NIH-11193553 on ClinicalTrials.gov |
What this research studies
This research focuses on creating safe and effective contraceptive methods by investigating compounds that can disrupt reproductive processes such as ovulation and sperm function. The Biological Testing Facility (BTF) will evaluate new and existing chemical formulations, drug delivery systems, and devices aimed at contraception. Through various testing methods, including laboratory and animal studies, the project aims to gather data necessary for regulatory approval of new contraceptive options.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals interested in new contraceptive options, particularly those who may not find current methods suitable.
Not a fit: Patients who are not seeking contraceptive solutions or those who have contraindications to hormonal or chemical contraceptives may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative contraceptive methods that provide more choices and improved safety for individuals seeking to prevent pregnancy.
How similar studies have performed: Previous research in contraceptive development has shown promise, indicating that innovative approaches can lead to successful new contraceptive methods.
Where this research is happening
MENLO PARK, UNITED STATES
- SRI INTERNATIONAL — MENLO PARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BURNIN, DEBRA — SRI INTERNATIONAL
- Study coordinator: BURNIN, DEBRA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.